HOME ABOUT US NEWS CONTACT US

Home   |   News

03 Dec 2012

HAYWARD, Ca., December 3, 2012 — CogENT Therapeutics, LLC, an innovative ear, nose and throat medical device company, announced today the US launch of its first commercial product, the XeroGel® nasal/epistaxis pack. XeroGel provides a unique combination of inherent hemostatic properties, turgidity during wound healing and thorough, consistent dissolution to enhance patient comfort during follow up exams.

Download the PDF →

23 Oct 2012

HAYWARD, Ca., October 23, 2012 — CogENT Therapeutics, LLC, an innovative ear, nose and throat medical device company, announced today the FDA 510(k) approval of its first commercial product, the XeroGel® nasal/epistaxis pack, a novel product indicated for use in nasal/sinus surgery to minimize bleeding, separate tissues, prevent adhesion formation between mucosal surfaces, aid in the natural wound healing process, and treat epistaxis.

Download the PDF →